智通财经APP讯，易点云(02416)发布公告，于2025年11月3日，该公司斥资71.01万港元回购36万股股 份，每股回购价格为1.95-1.98港元。 ...

Core Points - Baofa Holdings (08532) has announced that it has met the resumption guidelines and has applied to the Hong Kong Stock Exchange for the resumption of trading of its shares starting from 9:00 AM on November 4, 2025 [1] Summary by Category - **Company Announcement** - Baofa Holdings has successfully reached the necessary conditions for resumption and has submitted an application to the stock exchange [1] - The trading of Baofa Holdings' shares is set to resume on November 4, 2025, at 9:00 AM [1] - **Market Impact** - The resumption of trading may indicate a positive development for the company, potentially restoring investor confidence [1] - The specific date for resumption has been officially communicated, which may influence market sentiment [1]

Core Insights - The "International Lung Cancer Frontier and Innovation Forum" held in Shanghai serves as a significant platform for discussing advancements in lung cancer treatment and showcases the R&D capabilities of local innovative pharmaceutical companies [1][2] - The company, Junshi Biosciences, presented its key innovative product, the PD-L1 antibody-drug conjugate (ADC) HLX43, which has garnered attention for its "high efficiency, low toxicity, and broad spectrum" data [1][2] Company Strategy - The CEO of Junshi Biosciences, Dr. Zhu Jun, emphasized the company's strategic vision in his keynote speech, highlighting lung cancer as the most prevalent malignant tumor globally and in China [2] - The company has successfully launched nine products, benefiting over 900,000 patients worldwide, and has introduced the world's first approved anti-PD-1 monoclonal antibody for first-line treatment of small cell lung cancer (SCLC) in nearly 40 countries [2][3] R&D Pipeline - Junshi Biosciences is focusing on a differentiated R&D platform and global integrated operational system to achieve breakthroughs in lung cancer treatment [3] - The PD-L1 ADC HLX43 is expected to overcome limitations related to PD-L1 expression levels and EGFR gene mutations, thus covering a broader patient population [3][4] HLX43 Data Highlights - The forum featured significant updates on HLX43's efficacy and safety for treating non-small cell lung cancer (NSCLC), combining data from Chinese Phase I and international Phase II studies [5][8] - HLX43 demonstrated a "biomarker-independent" broad efficacy, showing treatment effects across various patient demographics, including squamous and non-squamous NSCLC, regardless of EGFR mutation status or PD-L1 expression levels [8][10] Clinical Value - In difficult-to-treat patient populations, HLX43 achieved objective response rates (ORR) of 33.3% for squamous NSCLC and 48.6% for non-squamous NSCLC, addressing the pressing issue of immunotherapy resistance [10][11] - The drug also showed promising intracranial activity, with a 30.0% ORR and a 90.0% disease control rate in patients with brain metastases, indicating its potential for treating other solid tumors prone to brain metastasis [10][11] Market Recognition - Leading investment institutions, including Goldman Sachs, have recognized Junshi Biosciences' innovative transformation, issuing a "buy" rating with a 12-month target price of HKD 100.70, indicating strong potential upside [12][13] - The report highlights HLX43's dual potential as "first-in-class" and "best-in-class," with its global potential seen as a key driver for the company's valuation [12][13] Future Outlook - The successful forum and HLX43 data release mark a milestone for Junshi Biosciences, showcasing its capability to produce globally competitive innovative drugs [13] - The broad applicability and ability to address clinical challenges position HLX43 as a potential cornerstone product for the company, with expectations for significant market impact as clinical trials progress [13]

TL NATURAL GAS(08536)发布公告，于2025年11月3日，公司与华特动力(中国)有限公司(华特动力)及 税阳订立谅解备忘录，内容有关建议成立合营企业，据此，订约方同意共同成立一家合营企业，以从事 深圳超算力量数字科技有限公司与华特动力在全国范围内合作开发及部署的甲醇氢燃料电池离网供电系 统及液冷式超级充电站(包括但不限于已投入运营及在建中的项目)的管理及营运业务。根据谅解备忘 录，建议合营企业由公司持有51%权益、华特动力持有24.5%权益，以及税阳持有24.5%权益。相关经营 计划及建议成立合营企业的更多详情，将于签立正式协议后作出公布。 集团主要于中国从事压缩天然气及液化天然气销售以及提供输送服务。董事认为，建议成立合营企业将 使集团得以进入电力收费市场，从而为集团带来额外收入。 ...

消息发布后，微软盘前小幅上涨，而英伟达股价上涨2%。 史密斯还披露了出口许可的具体细节：该许可由美国商务部于9月批准，允许微软向阿联酋额外运送等 效于60400个A100芯片的产品，以及部分英伟达GB300GPU。 "尽管这些芯片性能强大、数量可观，但更重要的是它们将为阿联酋带来积极影响，"史密斯补充 道，"我们将利用这些GPU，让用户能够使用来自OpenAI、Anthropic、开源提供商以及微软自身的先进 AI模型; 我们将为各类本地及国际提供商开发的AI应用(包括我们的Copilot应用)提供支持;同时，我们将与G42合 作，为阿联酋各行业的公共和私营部门机构，以及全国消费者提供支持。" 此前，微软已获得拜登政府批准，可在阿联酋部署等效于21500个英伟达A100GPU的产品，这些产品包 含A100、H100及H200芯片。 这笔152亿美元的投资包含：对阿联酋企业G42的15亿美元股权投资;超46亿美元用于在阿联酋建设先进 AI及云数据中心的资本支出;超12亿美元的本地运营支出。 微软副董事长兼总裁布拉德.史密斯(Brad Smith)在一篇博客文章中指出，从明年起至2029年，微软将在 阿联酋追加超 ...

万国黄金集团(03939.HK)发布公告，董事会建议将每1股每股面值0.1港元的现有已发行及未发行股份拆 细为4股每股面值 0.025港元的经拆细股份。于股份拆细生效后，本公司的法定股本将为10亿港元，分为 400亿股经拆细股份，其中44.25亿股经拆细股份将为已发行及悉数缴足或入账列作悉数缴足(假设于本 公告日期后及股份拆细生效前并无进一步发行或购回股份)。 | 指标 | 万国黄金集团 | 工业务属 行业平均 | 行业排名 | | --- | --- | --- | --- | | ROE | 25.96% | 7.95% | 1 16 | | 港股流通市值 | 339.86 Z | 417.36 乙 | 8 16 | | 营业收入 | 21.88 乙 | 649.32 Z | 12 16 | | 净利率 | 53.64% | -2.61% | 1 16 | | 毛利率 | 69.97% | 22.89% | 2 16 | | 员债率 | 17.53% | 78.66% | 1 16 | 截至2025年11月3日收盘，万国黄金集团(03939.HK)报收于30.74港元，上涨0.07%，成交量207.37万 ...

财讯传媒(00205)发布公告，公司董事会建议将公司英文名称由"SEEC Media Group Limited"更改为"BFB Health Limited"，并将公司中文名称"财讯传媒集团有限公司"删除。 ...

US stock futures went up on Monday morning. Wall Street wanted to continue the strong momentum it had in October. Market gains were seen across indexes. S&P 500 futures (ES=F) rose 0.3%, Nasdaq 100 futures (NQ=F) jumped 0.6%, Dow Jones Industrial Average futures (YM=F) added about 0.1%. October was a strong month for stocks. The S&P 500 (^GSPC) rose 2.3%, the Dow (^DJI) gained 2.5%, and the Nasdaq Composite (^IXIC) climbed 4.7%. This was led by investor interest in growth and AI-linked companies, especially ...

格隆汇11月3日丨财讯传媒(00205.HK)公告，建议将公司英文名称由「SEEC Media Group Limited」更改 为「BFB Health Limited」，并将公司中文名称「财讯传媒集团有限公司」删除。 ...

智通财经APP讯，财讯传媒(00205)发布公告，公司董事会建议将公司英文名称由"SEEC Media Group Limited"更改为"BFB Health Limited"，并将公司中文名称"财讯传媒集团有限公司"删除。 ...